Caige Li

发表

Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

miRNA-576 Alleviates the Malignant Progression of Atherosclerosis through Downregulating KLF5

Lijing Jiao, Yongjun Li, Jing Wang, 2021, Disease Markers.

The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2022, Evidence-based complementary and alternative medicine : eCAM.

Liraglutide, a glucagon-like peptide-1 analog, inhibits high glucose-induced oxidative stress and apoptosis in neonatal rat cardiomyocytes.

Lihui Zhang, Caige Li, Hong Zhou, 2019, Experimental and therapeutic medicine.

Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2022, Journal of Natural Medicines.

Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration

Yuehua Xue, Yiwei Liu, Yinglin Guo, 2022, World journal of clinical cases.

Cisplatin Increased the Expression of PD-1 and PD-L1 by YAP1 in Hepatocellular Carcinoma

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2021 .

Prophylactic Use of Troxerutin Can Delay the Development of Diabetic Cognitive Dysfunction and Improve the Expression of Nrf2 in the Hippocampus on STZ Diabetic Rats

J. Li, Lihui Zhang, Caige Li, 2018, Behavioural neurology.

Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti‐PD‐1 efficacy

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2022, Phytotherapy research : PTR.

Dihydroartemisinin broke immune evasion through YAP1/JAK1/STAT1, 3 pathways to enhance anti-PD-1 therapy in hepatocellular carcinoma

Yiwei Liu, Zhiqin Zhang, Yu-hua Xue, 2021, bioRxiv.

Wolfberry enhanced the abundance of Akkermansia muciniphila by YAP1 in mice with acetaminophen‐induced liver injury

Yuehua Xue, Yiwei Liu, Zhiqin Zhang, 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.

L. Hao, Yuehua Xue, Yiwei Liu, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease.

Yuehua Xue, Wenhan Zhou, Yiwei Liu, 2023, Journal of ethnopharmacology.

Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.

Yuehua Xue, Kun Yu, Yiwei Liu, 2023, Frontiers of medicine.